Instrumento Inactivo

Acciones Optimer Pharmaceuticals, Inc.

Acciones

Precio de cierre Nasdaq Otros sitios de cotización
- ^USD	-

Optimer Pharmaceuticals, Inc. : Pre-Market Analysis: Inovio Pharmaceuticals Inc., Sequenom Inc., and Optimer Pharmaceuticals Inc.	04/10/13
Optimer Pharmaceuticals, Inc. : Today's Research: Inovio Pharmaceuticals Inc., Onyx Pharmaceuticals Inc., Sequenom Inc. and Optimer Pharmaceuticals Inc.	29/08/13
Optimer Pharmaceuticals, Inc. : Laboratory Permits, Pending FDA Approvals, Clinical Study Presentations, and Financial Results Release - Research Report on Illumina, Theravance, Acorda, Synta, and Optimer	12/08/13
Optimer Pharmaceuticals, Inc. : Ryan & Maniskas, LLP Announces Investigation of Optimer Pharmaceuticals, Inc.	01/08/13
Optimer Pharmaceuticals, Inc. : Optimer Reports Second Quarter 2013 Financial Results	01/08/13

Sector

	Varia. 1 de ene.	Capi.
CSL LIMITED	-1,98 %	88,14 mil M
SAMSUNG BIOLOGICS CO.,LTD.	+3,29 %	40,44 mil M
BIOGEN INC.	-15,40 %	32,24 mil M
UCB	+51,96 %	24,39 mil M
BIOMARIN PHARMACEUTICAL INC.	-14,35 %	15,59 mil M
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-39,65 %	12,3 mil M
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-6,52 %	12,18 mil M
INCYTE CORPORATION	-13,41 %	12,14 mil M
SWEDISH ORPHAN BIOVITRUM AB	+5,17 %	8870,65 M